Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
Same as current

Summary

Conditions
  • Diabetes Mellitus - Type 2
  • Pre Diabetes
Type
Observational
Design
Observational Model: Case-ControlTime Perspective: Prospective

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Description

In addition, lifestyle and treatment already established for prediabetes and Type 2 Diabetes such as: Sleep Exercise/Physical activity/or lack of it Heart rate Five hours OGTT- 6 subjects in each group that have C-Peptide positive lab result at screening and consent to the OGTT (Appendix 3) This dat...

In addition, lifestyle and treatment already established for prediabetes and Type 2 Diabetes such as: Sleep Exercise/Physical activity/or lack of it Heart rate Five hours OGTT- 6 subjects in each group that have C-Peptide positive lab result at screening and consent to the OGTT (Appendix 3) This data will address the sources and nature of blood glucose variability across the progression of PD and T2D. The data collected in this study will enable investigation into CGM-data artifacts that speak to the state and management of PD and T2D. Possible applications enabled by these data sets include: compliance with drug regimens and other lifestyle recommendations, drug titration and/or escalation/de-escalation, and diagnosis and/or treatment throughout the progression of the disease.

Tracking Information

NCT #
NCT04503239
Collaborators
Not Provided
Investigators
Study Director: Danny Chernavvsky, MD DexCom, Inc.